Concern about the Food and Drug Administration's drug approval process

被引：0
|
作者：
不详
机构：
来源：
AMERICAN JOURNAL OF PUBLIC HEALTH | 2000年 / 90卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：466 / 467
页数：2
相关论文
共 50 条
  • [31] Transparency and Dermatologic Device Approval by the US Food and Drug Administration
    Ezaldein, Harib H.
    Scott, Jeffrey F.
    Yin, Emily S.
    Ventura, Alessandra
    DeRuyter, Nicholaas P.
    Leffell, David J.
    JAMA DERMATOLOGY, 2018, 154 (03) : 273 - 280
  • [32] Food and Drug Administration Requirements for Testing and Approval of New Radiopharmaceuticals
    Harapanhalli, Ravi S.
    SEMINARS IN NUCLEAR MEDICINE, 2010, 40 (05) : 364 - 384
  • [33] Product Approval and Public Health at the US Food and Drug Administration
    Lurie, Peter
    Sharfstein, Joshua M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (24): : 2469 - 2470
  • [34] Vaccine for rotavirus seeks approval from the Food and Drug Administration
    Potera, C
    GENETIC ENGINEERING NEWS, 1997, 17 (21): : 24 - +
  • [35] Accelerated Approval of Oncology Products: The Food and Drug Administration Experience
    Johnson, John R.
    Ning, Yang-Min
    Farrell, Ann
    Justice, Robert
    Keegan, Patricia
    Pazdur, Richard
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (08) : 636 - 644
  • [36] U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
    Herndon, Thomas M.
    Deisseroth, Albert
    Kaminskas, Edvardas
    Kane, Robert C.
    Koti, Kallappa M.
    Rothmann, Mark D.
    Habtemariam, Bahru
    Bullock, Julie
    Bray, Jeffrey D.
    Hawes, Jessica
    Palmby, Todd R.
    Jee, Josephine
    Adams, William
    Mahayni, Houda
    Brown, Janice
    Dorantes, Angelica
    Sridhara, Rajeshwari
    Farrell, Ann T.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2013, 19 (17) : 4559 - 4563
  • [37] US Food and Drug Administration's Approval of Aripiprazole Tablets With Sensor: Our Perspective
    Lee, Daniel J.
    Farchione, Tiffany R.
    Mathis, Mitchell V.
    Muniz, Javier
    Muoio, Brendan M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2018, 79 (03)
  • [38] Vilazodone: Clinical Basis for the US Food and Drug Administration's Approval of a New Antidepressant
    Laughren, Thomas P.
    Gobburu, Jogarao
    Temple, Robert J.
    Unger, Ellis F.
    Bhattaram, Atul
    Dinh, Phillip V.
    Fossom, Linda
    Hung, H. M. James
    Klimek, Violetta
    Lee, Jee Eun
    Levin, Robert L.
    Lindberg, Cheri Y.
    Mathis, Mitchell
    Rosloff, Barry N.
    Wang, Sue-Jane
    Wang, Yaning
    Yang, Peiling
    Yu, Bei
    Zhang, Huixia
    Zhang, Li
    Zineh, Issam
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (09) : 1166 - 1173
  • [39] THE ROLE OF CLINICAL-TRIALS IN THE FOOD-AND-DRUG-ADMINISTRATION APPROVAL PROCESS FOR CARDIOVASCULAR DEVICES
    SAPIRSTEIN, W
    ALPERT, S
    CALLAHAN, TJ
    CIRCULATION, 1994, 89 (04) : 1900 - 1902
  • [40] Carvedilol and the food and drug administration (FDA) approval process: The FDA paradigm and reflections on hypothesis testing
    Fisher, LD
    CONTROLLED CLINICAL TRIALS, 1999, 20 (01): : 16 - 39
12345